Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hecht

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancerJong-Ho Kim, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Assisted Reproduction and Genetics|February 1, 1997
Strategies for ovulation induction and oocyte retrieval in the lowland gorillaH H Hatasaka, N E Schaffer, P E Chenette, et al.
Obstetrics and Gynecology|September 23, 2010
Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trialAndrea S Lukes, Keith A Moore, Ken N Muse, et al.
Blood|December 15, 1995
Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in miceM M Hokom, D Lacey, O B Kinstler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal CancerAxel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
ESMO Open|March 2, 2023
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastasesJ R Hecht, S S Raman, A Chan, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancerJong-Ho Kim, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Assisted Reproduction and Genetics|February 1, 1997
Strategies for ovulation induction and oocyte retrieval in the lowland gorillaH H Hatasaka, N E Schaffer, P E Chenette, et al.
Obstetrics and Gynecology|September 23, 2010
Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trialAndrea S Lukes, Keith A Moore, Ken N Muse, et al.
Blood|December 15, 1995
Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in miceM M Hokom, D Lacey, O B Kinstler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal CancerAxel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
ESMO Open|March 2, 2023
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastasesJ R Hecht, S S Raman, A Chan, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Pageof 11